Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Standard Chemotherapy”

840 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 840 results

Testing effectiveness (Phase 2)Study completedNCT03746080
What this trial is testing

Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma With Primitive Neuronal ComponentGliosarcoma+2 more
Lawrence D Recht 21
Large-scale testing (Phase 3)Looking for participantsNCT02582697
What this trial is testing

Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

Who this might be right for
Germ Cell Tumor
University of Sydney 500
Testing effectiveness (Phase 2)Study completedNCT00994097
What this trial is testing

NGR-hTNF in Combination With Standard Chemotherapy to Treat Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
AGC Biologics S.p.A. 121
Testing effectiveness (Phase 2)Active Not RecruitingNCT04817241
What this trial is testing

Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 5
Early research (Phase 1)Ended earlyNCT00121745
What this trial is testing

Evaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Epeius Biotechnologies 12
Testing effectiveness (Phase 2)Looking for participantsNCT07506057
What this trial is testing

Trastuzumab in Combination With Serplulimab and Chemotherapy for the Treatment of HER2-overexpressing Unresectable Locally Advanced or Metastatic Biliary Tract Cancer or Urothelial Carcinoma After Failure of Standard Therapy

Who this might be right for
Urothelial CarcinomaBiliary Tract CancerHER2
Xiujuan Qu 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT01871766
What this trial is testing

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

Who this might be right for
Rhabdomyosarcoma
St. Jude Children's Research Hospital 115
Testing effectiveness (Phase 2)Looking for participantsNCT05770531
What this trial is testing

Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy

Who this might be right for
Metastatic HER2-Negative Breast CarcinomaMetastatic Triple-Negative Breast Carcinoma
Vanderbilt-Ingram Cancer Center 160
Testing effectiveness (Phase 2)Ended earlyNCT01018069
What this trial is testing

AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen

Who this might be right for
Leukemia
Aegera Therapeutics 60
Testing effectiveness (Phase 2)Study completedNCT00066846
What this trial is testing

Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06933966
What this trial is testing

Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma

Who this might be right for
Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaNon Metastatic Disease
Centre Leon Berard 120
Large-scale testing (Phase 3)Looking for participantsNCT05566795
What this trial is testing

DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)

Who this might be right for
Low-grade GliomaRapidly Accelerated Fibrosarcoma (RAF) Altered GliomaPediatric Low-grade Glioma
Day One Biopharmaceuticals, Inc. 400
Not applicableLooking for participantsNCT05644431
What this trial is testing

GastrOesophageal Tumor, Immune Microenvionnment (GOTIM)

Who this might be right for
GastroEsophageal Cancer
Centre Leon Berard 50
Not applicableLooking for participantsNCT06456515
What this trial is testing

Regorafenib and Sintilimab in Combination with Electroacupuncture in MSS CRC

Who this might be right for
Colorectal Cancer Metastatic
The First People's Hospital of Changzhou 30
Large-scale testing (Phase 3)Active Not RecruitingNCT04884360
What this trial is testing

D9319C00001- 1L OC Mono Global RCT

Who this might be right for
Ovarian Cancer
AstraZeneca 366
Post-approval studies (Phase 4)Ended earlyNCT00418678
What this trial is testing

A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting

Who this might be right for
Nausea and Vomiting
Veeda Oncology 16
Not applicableActive Not RecruitingNCT01872975
What this trial is testing

Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery

Who this might be right for
Stage IB Breast CancerStage II Breast Cancer
NSABP Foundation Inc 1,636
Large-scale testing (Phase 3)Study completedNCT01607957
What this trial is testing

Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies

Who this might be right for
Colorectal Cancer
Taiho Oncology, Inc. 800
Early research (Phase 1)Study completedNCT01675765
What this trial is testing

Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Aduro Biotech, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT00416624
What this trial is testing

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Mayo Clinic 239
Load More Results